90% reductions in symptoms, clearance of outbreaks, a massive reduction
data strong
A perfect scenario for AHZ....continued monthly injections boosts income by a 1000 fold rather than a one and done injection.
I predicted in 2014/2015 this very same outcome after the phase1 results and Mice testing
Partnering is next as Baillieu Holst predicted in 2014
- US $200M-$500M cash up front
- 14% royalties (potential annual $150M revenue stream there alone)
- milestone payments for phase 3
(no debt and no cheap CR please and NO US Pharmas please)
Now we will see if Patterson a Merck hack and Turvey a CSL hack can get their moneys worth for all those free shares, negotiating a partner deal is all down hill
Cmon Turvey you are supposed to be the partnering expert on AHZs board...get some offers in now from Aust pharma like CSL or Euro pharma like Sanofi whose factory was given AHZ in a sweetheart deal. Pay back Sanofi please with a great deal.
Dont trust the yanks and their hedge funds like Sabby. They will try to white ant us and look trying to short yet again now from 56c-47c...hahahah
Daily profits but LT buying soon as Instos and Pitt street kids start taking notice again.
What valuation do you put on a 90% probability of sucess for the vaxs?
But wait BH already worked that out in 2014...its a SP of $5.50!
Yes $5.50 with a low range of $2.50 for a 25% probability!
